SMAD4 and cancer: Our results are important because many components of the TGF-β signaling pathway are mutated, downregulated, or overexpressed in multiple diseases, such as the TGF-β receptors, R-Smads, Smad4, and Smad7 proteins in a variety of cancer types [3].